{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:53Z","timestamp":1781650373005,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["POSGRAD Program - #002\/2025 and #015\/2026"],"award-info":[{"award-number":["POSGRAD Program - #002\/2025 and #015\/2026"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","award":["PR\u00d3-ESTADO Program - #002\/2008, #007\/2018, #005\/2019"],"award-info":[{"award-number":["PR\u00d3-ESTADO Program - #002\/2008, #007\/2018, #005\/2019"]}],"id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["INCT-Sangue \u2013 Process #405918\/2022-4"],"award-info":[{"award-number":["INCT-Sangue \u2013 Process #405918\/2022-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PDPG-CONSOLIDACAO-3-4 Program \u2013 Process #88887.707248\/2022-00"],"award-info":[{"award-number":["PDPG-CONSOLIDACAO-3-4 Program \u2013 Process #88887.707248\/2022-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tumor suppressor genes play a central role in cancer development, and inherited genetic variation may influence both disease susceptibility and clinical outcomes. This study aimed to investigate the frequency and prognostic relevance of\n                      <jats:italic>TP53<\/jats:italic>\n                      polymorphic variants in patients with acute lymphoblastic leukemia (ALL) from an admixed population in the Brazilian Amazon.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A population-based case\u2013control study was conducted including 193 patients diagnosed with ALL and 215 healthy controls. Germline\n                      <jats:italic>TP53<\/jats:italic>\n                      polymorphisms\n                      <jats:italic>rs1042522<\/jats:italic>\n                      and\n                      <jats:italic>rs1642785<\/jats:italic>\n                      were genotyped, and allele and genotype frequencies were compared between groups. Associations with ALL susceptibility, relapse, and mortality were evaluated using multiple genetic models adjusted for age and sex. Combined genotype and haplotype analyses were performed, and overall survival was estimated using Kaplan-Meier curves and log-rank tests.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The CC genotype and the allele C were more frequent among ALL cases than controls. The allele C of\n                      <jats:italic>rs1042522<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.021) and\n                      <jats:italic>rs1642785<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022) was associated with increased susceptibility to ALL. In addition, the allele C of\n                      <jats:italic>rs1042522<\/jats:italic>\n                      was associated with a higher risk of relapse (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) and death (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009). Protective effects against ALL were observed under the recessive model for\n                      <jats:italic>rs1042522<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019) and the codominant model for\n                      <jats:italic>rs1642785<\/jats:italic>\n                      (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013). Both variants showed protective associations with mortality under the log-additive model. Combined genotype analysis revealed that the CG and GG genotypes of\n                      <jats:italic>rs1042522<\/jats:italic>\n                      were associated with a reduced risk of relapse (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Overall survival analysis showed reduced survival associated with the CC genotype, whereas improved survival was observed for the heterozygous CG genotype. Haplotype analysis indicated that the GG haplotype was associated with a reduced risk of ALL (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007) and death (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.013).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings suggest that germline\n                      <jats:italic>TP53<\/jats:italic>\n                      variants\n                      <jats:italic>rs1042522<\/jats:italic>\n                      and\n                      <jats:italic>rs1642785<\/jats:italic>\n                      modulate susceptibility and clinical outcomes in ALL, supporting their potential role as prognostic biomarkers. This study highlights the importance of population-based genomic investigations in underrepresented populations.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-026-02371-0","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:14:56Z","timestamp":1776147296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of TP53 polymorphic variants rs1042522 and rs1642785 with susceptibility and prognosis of acute lymphoblastic leukemia in a Brazilian Amazon population"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-7766","authenticated-orcid":false,"given":"Glenda Menezes","family":"Nogueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2839-8253","authenticated-orcid":false,"given":"Luca Gabriel Marques","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-4472","authenticated-orcid":false,"given":"Tha\u00eds Lohana","family":"Pereira-Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4125-8239","authenticated-orcid":false,"given":"Larissa Silva","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1373-0953","authenticated-orcid":false,"given":"F\u00e1bio","family":"Magalh\u00e3es-Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2107-3677","authenticated-orcid":false,"given":"Nilberto Dias","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1107-8079","authenticated-orcid":false,"given":"Adriana","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3125-580X","authenticated-orcid":false,"given":"Andr\u00e9a Monteiro","family":"Tarrag\u00f4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1582-2969","authenticated-orcid":false,"given":"Fab\u00edola Silva","family":"Alves-Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-6822","authenticated-orcid":false,"given":"Allyson Guimar\u00e3es","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"1","key":"2371_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s11033-020-06073-3","volume":"48","author":"TC Fujita","year":"2021","unstructured":"Fujita TC, Sousa-Pereira N, Amarante MK, Watanabe MAE. Acute lymphoid leukemia etiopathogenesis. Mol Biol Rep. 2021;48(1):817\u201322.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"2371_CR2","doi-asserted-by":"publisher","first-page":"e577","DOI":"10.1038\/bcj.2017.53","volume":"7","author":"T Terwilliger","year":"2017","unstructured":"Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.","journal-title":"Blood Cancer J"},{"key":"2371_CR3","volume-title":"Estimativa 2023: incid\u00eancia de c\u00e2ncer no Brasil","author":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva (INCA)","year":"2022","unstructured":"Instituto Nacional de C\u00e2ncer Jos\u00e9 Alencar Gomes da Silva (INCA). Estimativa 2023: incid\u00eancia de c\u00e2ncer no Brasil. Rio de Janeiro: INCA; 2022."},{"issue":"10230","key":"2371_CR4","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230):1146\u201362.","journal-title":"Lancet"},{"issue":"11","key":"2371_CR5","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","volume":"105","author":"H Inaba","year":"2020","unstructured":"Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. Haematologica. 2020;105(11):2524\u201339.","journal-title":"Haematologica"},{"issue":"4","key":"2371_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tcb.2020.12.011","volume":"31","author":"AM Boutelle","year":"2021","unstructured":"Boutelle AM, Attardi LD. p53 and tumor suppression: it takes a network. Trends Cell Biol. 2021;31(4):298\u2013310.","journal-title":"Trends Cell Biol"},{"key":"2371_CR7","doi-asserted-by":"publisher","first-page":"1272876","DOI":"10.3389\/fonc.2023.1272876","volume":"13","author":"A Ounalli","year":"2023","unstructured":"Ounalli A, Moumni I, Mechaal A, Chakroun A, Barmat M, Rhim REE, et al. TP53 Gene 72 Arg\/Pro (rs1042522) single nucleotide polymorphism increases the risk and the severity of chronic lymphocytic leukemia. Front Oncol. 2023;13:1272876.","journal-title":"Front Oncol"},{"issue":"6","key":"2371_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9061672","volume":"9","author":"F Tripon","year":"2020","unstructured":"Tripon F, Iancu M, Trifa A, Crauciuc GA, Boglis A, Balla B, et al. Association analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 variants and acute myeloid leukemia susceptibility and clinical features: an exploratory study. J Clin Med. 2020;9(6):1\u201316.","journal-title":"J Clin Med"},{"key":"2371_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2017.03.009","volume":"58","author":"N Bilous","year":"2017","unstructured":"Bilous N, Abramenko I, Saenko V, Chumak A, Dyagil I, Martina Z, et al. Clinical relevance of TP53 polymorphic genetic variations in chronic lymphocytic leukemia. Leuk Res. 2017;58:1\u20138.","journal-title":"Leuk Res"},{"key":"2371_CR10","doi-asserted-by":"crossref","unstructured":"Silva-Junior AL, Alves FS, Kerr MWA, Xabregas LA, Gama FM, Rodrigues MGA et al. E <>Jabbour editor 2019 Acute lymphoid and myeloid leukemia in a Brazilian Amazon population. PLoS ONE 14 8 e0221518.","DOI":"10.1371\/journal.pone.0221518"},{"issue":"1","key":"2371_CR11","doi-asserted-by":"publisher","first-page":"9869","DOI":"10.1038\/s41598-021-89310-4","volume":"11","author":"FS Alves","year":"2021","unstructured":"Alves FS, Xabregas LA, Kerr MWA, Souza GL, Pereira DS, Magalh\u00e3es-Gama F, et al. Genetic polymorphisms of inflammasome genes associated with pediatric acute lymphoblastic leukemia and clinical prognosis in the Brazilian Amazon. Sci Rep. 2021;11(1):9869.","journal-title":"Sci Rep"},{"issue":"11","key":"2371_CR12","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","volume":"118","author":"J Zhang","year":"2011","unstructured":"Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M, et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children\u2019s oncology group. Blood. 2011;118(11):3080\u20137.","journal-title":"Blood"},{"issue":"27","key":"2371_CR13","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"CH Pui","year":"2015","unstructured":"Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33(27):2938\u201348.","journal-title":"J Clin Oncol"},{"key":"2371_CR14","doi-asserted-by":"publisher","unstructured":"Skhoun H, Khattab M, Belkhayat A, Takki Chebihi Z, Bakri Y, Dakka N, et al. Association of TP53 gene polymorphisms with the risk of acute lymphoblastic leukemia in Moroccan children. Mol Biol Rep. 2022;49(9):8291\u2013300. https:\/\/doi.org\/10.1007\/s11033-022-07643-3.","DOI":"10.1007\/s11033-022-07643-3"},{"issue":"5","key":"2371_CR15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41418-020-00672-0","volume":"28","author":"F Doffe","year":"2021","unstructured":"Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson JSM, et al. Identification and functional characterization of new missense SNPs in TP53. Cell Death Differ. 2021;28(5):1477\u201392.","journal-title":"Cell Death Differ"},{"issue":"7","key":"2371_CR16","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1007\/s11033-013-2551-1","volume":"40","author":"A de Lourdes Perim","year":"2013","unstructured":"de Lourdes Perim A, Guembarovski RL, Oda JMM, Lopes LF, Ariza CB, Amarante MK, et al. CXCL12 and TP53 polymorphisms as markers of susceptibility in a Brazilian children population with ALL. Mol Biol Rep. 2013;40(7):4591\u20136.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"2371_CR17","doi-asserted-by":"publisher","first-page":"24097","DOI":"10.1038\/srep24097","volume":"6","author":"X Tian","year":"2016","unstructured":"Tian X, Dai S, Sun J, Jiang S, Jiang Y. TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis. Sci Rep. 2016;6(1):24097.","journal-title":"Sci Rep"},{"issue":"5","key":"2371_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.31557\/APJCP.2019.20.5.1579","volume":"20","author":"AA Mohammed Basabaeen","year":"2019","unstructured":"Mohammed Basabaeen AA, Abdelgader EA, Babekir EA, Abdelrahim SO, Eltayeb NH, Altayeb OA, et al. TP53 Arg72Pro and B-CLL risk in the Sudanese Population. Asian Pac J Cancer Prev. 2019;20(5):1579\u201385.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"2371_CR19","doi-asserted-by":"publisher","first-page":"102936","DOI":"10.1016\/j.jksus.2023.102936","volume":"35","author":"AM Alhadheq","year":"2023","unstructured":"Alhadheq AM, Parine NR, Shaik JP, Alhadheq R, Alkahtani S, Aljarba NH, et al. TP53 Polymorphisms and colorectal cancer risk. J King Saud Univ - Sci. 2023;35(10):102936.","journal-title":"J King Saud Univ - Sci"},{"issue":"1","key":"2371_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10689-016-9931-3","volume":"16","author":"WS Hamadou","year":"2017","unstructured":"Hamadou WS, Besbes S, Bourdon V, Youssef Y, Ben, Laatiri MA, Noguchi T, et al. TP53 mutations in familial and sporadic hematological malignancies. Fam Cancer. 2017;16(1):153\u20137.","journal-title":"Fam Cancer"},{"issue":"3","key":"2371_CR21","doi-asserted-by":"publisher","first-page":"224","DOI":"10.32471\/exp-oncology.2312-8852.vol-43-no-3.16474","volume":"43","author":"I Abramenko","year":"2021","unstructured":"Abramenko I, Bilous N, Chumak A, Dyagil I, Martina Z. Lipoprotein lipase expression and TP53 polymorphisms in CLL. Exp Oncol. 2021;43(3):224\u20138.","journal-title":"Exp Oncol"},{"issue":"12","key":"2371_CR22","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/carcin\/bgu206","volume":"35","author":"L Perriaud","year":"2014","unstructured":"Perriaud L, Marcel V, Sagne C, Favaudon V, Gu\u00e9din A, De Rache A, et al. I intronic polymorphisms rs17878362 and rs1642785 effect TP53 transcripts. Carcinogenesis. 2014;35(12):2706\u201315.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2371_CR23","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","volume":"1876","author":"LJ Hern\u00e1ndez Borrero","year":"2021","unstructured":"Hern\u00e1ndez Borrero LJ, El-Deiry WS. Tumor suppressor p53: Biology and therapeutic targeting. Biochim Biophys Acta - Rev Cancer. 2021;1876(1):188556.","journal-title":"Biochim Biophys Acta - Rev Cancer"},{"issue":"2","key":"2371_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yexmp.2010.11.002","volume":"90","author":"P Jha","year":"2011","unstructured":"Jha P, Jha P, Pathak P, Chosdol K, Suri V, Sharma MC, et al. TP53 polymorphisms in gliomas from Indian patients. Exp Mol Pathol. 2011;90(2):167\u201372.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"2371_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood-2024-208796","volume":"144","author":"T Liu","year":"2024","unstructured":"Liu T, Langie J, Yang W, Morimoto L, Ma X, Metayer C, et al. Genome-wide association study of all in Hispanic\/Latino children identifies a putatively novel risk locus at chromosome 5q31.1. Blood. 2024;144(1):317\u2013317.","journal-title":"Blood"},{"issue":"1","key":"2371_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2017-03-774422","volume":"130","author":"AJ de Smith","year":"2017","unstructured":"de Smith AJ, Walsh KM, Francis SS, Gonseth S, Hansen HM, Smirnov I, et al. Large multi-ethnic genome wide association study reveals novel genetic associations with childhood all at chromosomes 8q24 and 17q12. Blood. 2017;130(1):30\u201330.","journal-title":"Blood"},{"issue":"5","key":"2371_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ajhb.22714","volume":"27","author":"R Rodrigues de Moura","year":"2015","unstructured":"Rodrigues de Moura R, Coelho AVC, de Queiroz Balbino V, Crovella S, Brand\u00e3o LAC. Meta-analysis of Brazilian genetic admixture and comparison with other Latin America countries. Am J Hum Biol. 2015;27(5):674\u201380.","journal-title":"Am J Hum Biol"},{"key":"2371_CR28","doi-asserted-by":"publisher","unstructured":"Nunes K, Ara\u00fajo Castro e Silva M, Rodrigues MR, Lemes RB, Pezo-Valderrama P, Kimura L, et al. Admixture\u2019s impact on Brazilian population evolution and health. Science. 2025;388(6748):eadl3564. https:\/\/doi.org\/10.1126\/science.adl3564.","DOI":"10.1126\/science.adl3564"},{"issue":"1","key":"2371_CR29","doi-asserted-by":"publisher","first-page":"13900","DOI":"10.1038\/s41598-019-50362-2","volume":"9","author":"R Secolin","year":"2019","unstructured":"Secolin R, Mas-Sandoval A, Arauna LR, Torres FR, de Araujo TK, Santos ML, et al. Local ancestry and adaptation in admixed populations. Sci Rep. 2019;9(1):13900.","journal-title":"Sci Rep"},{"issue":"9","key":"2371_CR30","doi-asserted-by":"publisher","first-page":"e0137823","DOI":"10.1371\/journal.pone.0137823","volume":"10","author":"VC Jacovas","year":"2015","unstructured":"Jacovas VC, Rovaris DL, Per\u00e9z O, De Azevedo S, Macedo GS, Sandoval JR, et al. TP53 pathway in native Americans from the Andes. PLoS ONE. 2015;10(9):e0137823.","journal-title":"PLoS ONE"},{"issue":"13","key":"2371_CR31","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.3390\/ijms21134659","volume":"21","author":"CM Hattinger","year":"2020","unstructured":"Hattinger CM, Patrizio MP, Luppi S, Serra M. Pharmacogenomics and pharmacogenetics in osteosarcoma. Int J Mol Sci. 2020;21(13):4659.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"2371_CR32","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.3390\/cancers15194747","volume":"15","author":"S Popek-Marciniec","year":"2023","unstructured":"Popek-Marciniec S, Styk W, Wojcierowska-Litwin M, Chocholska S, Szudy-Szczyrek A, Samardakiewicz M, et al. TP53 rs1042522 variant with multiple myeloma risk and response. Cancers (Basel). 2023;15(19):4747.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2371_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3892\/ol.2022.13451","volume":"24","author":"M Floris","year":"2022","unstructured":"Floris M, Pira G, Castiglia P, Idda ML, Steri M, de Miglio MR, et al. ITP53 polymorphisms and cancer susceptibility. Oncol Lett. 2022;24(4):331.","journal-title":"Oncol Lett"},{"issue":"21","key":"2371_CR34","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1182\/blood.V120.21.2497.2497","volume":"120","author":"I Iacobucci","year":"2012","unstructured":"Iacobucci I, Ferrari A, Kohlmann A, Papayannidis C, Venturi C, Perricone M, et al. Loss of heterozygosity at rs1042522 in BCR-ABL1\u2009+\u2009ALL. Blood. 2012;120(21):2497\u20132497.","journal-title":"Blood"},{"issue":"1","key":"2371_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00427-x","volume":"7","author":"JB Kodal","year":"2017","unstructured":"Kodal JB, Vedel-Krogh S, Kobylecki CJ, Nordestgaard BG, Bojesen SE. TP53 Arg72Pro, mortality after cancer. Sci Rep. 2017;7(1):1\u20138.","journal-title":"Sci Rep"},{"issue":"1","key":"2371_CR36","first-page":"1","volume":"20","author":"CC Shen","year":"2020","unstructured":"Shen CC, Cheng WY, Lee CH, Dai XJ, Chiao MT, Liang YJ, et al. TP53 codon 72 polymorphism and glioblastoma prognosis. BMC Cancer. 2020;20(1):1\u201313.","journal-title":"BMC Cancer"},{"issue":"4","key":"2371_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5603\/FHC.a2017.0022","volume":"55","author":"SA Zmorzynski","year":"2017","unstructured":"Zmorzynski SA, Korszen-Pilecka I, Wojcierowska-Litwin M, Kwiatkowska-Drabik B, Luterek M, Chocholska S, et al. TP53 polymorphism in plasma cell myeloma. Folia Histochem Cytobiol. 2017;55(4):203\u201311.","journal-title":"Folia Histochem Cytobiol"},{"issue":"38","key":"2371_CR38","doi-asserted-by":"publisher","first-page":"61970","DOI":"10.18632\/oncotarget.11486","volume":"7","author":"CM Hattinger","year":"2016","unstructured":"Hattinger CM, Biason P, Iacoboni E, Gagno S, Fanelli M, Tavanti E, et al. Germline polymorphisms and survival in osteosarcoma. Oncotarget. 2016;7(38):61970.","journal-title":"Oncotarget"},{"key":"2371_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2020.10.013","volume":"84","author":"TH Tran","year":"2022","unstructured":"Tran TH, Hunger SP. The genomic landscape of pediatric ALL. Semin Cancer Biol. 2022;84:144\u201352.","journal-title":"Semin Cancer Biol"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02371-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02371-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:59:17Z","timestamp":1781647157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02371-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2371"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02371-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8679558\/v1","asserted-by":"object"}]},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original contributions presented in the study are included in the article\/supplementary material, further inquiries can be directed to the corresponding author\/s. Due to ethical restrictions regarding patient privacy, data are available upon request. Data are available upon request from the Ethics Committee of HEMOAM (CEP-HEMOAM), cep@hemoam.am.gov.br, for researchers who meet the criteria for access to confidential data. Additional requests for the data may be sent to the corresponding author or coauthors Allyson G. Costa (allyson.gui.costa@gmail.com) and Fab\u00edola S. Alves-Hanna (fabiolasiilva@hotmail.com).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of interest"}},{"value":"All study protocols and informed consent procedures were approved by the Research Ethics Committee of HEMOAM (CEP\/HEMOAM; approval number 3,335,123\/2019). All patients were treated in accordance with the guidelines and recommendations of the Brazilian Ministry of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}